The groundbreaking therapy of tirzepatide peptide represents a exciting development in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide277721.oblogation.com/40876216/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment